Bioengineered Artificial Skin Market

Bioengineered Artificial Skin Market, By product type (Bilayered Bioengineered Artificial Skin , Trilayered Bioengineered Artificial Skin, Others), By Application (Chronic Wounds, Acute Wounds, Others), By End User (Hospitals, Clinics, Others), and By Geography (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

Bioengineered skin is designed to take over the functions of the epidermis and/or dermis until the patient's skin barrier spontaneously repairs itself. Bioengineered skin autografts are derived from the patient's own skin cells that are grown or cultured in small amounts of skin or hair follicles. Bioengineered artificial skin is designed for the reconstruction of skin appendages, pigmentation, and nerves. Artificial skin can replace or can be used to replace the outer layer of the skin or the thick layer just underneath it (epidermis and dermis).

Market Dynamics:

Rise in number of road accidents, burns, and trauma-related incidents, high incidence of acute and chronic wounds (owing to the rise in burden of chronic diseases and growing geriatric population), increasing awareness among people about various skin treatments, and rise in demand for artificial skin are major factors expected to drive growth of the global bioengineered artificial skin market.

For instance, in June 2021, the U.S. Food and Drug Administration (FDA) approved StrataGraft for the treatment of adult patients with thermal burns containing intact dermal elements (remaining deep skin layers) for which surgical intervention is clinically indicated (also referred to as deep partial thickness burns). StrataGraft is produced from two kinds of human skin cells (keratinocytes and dermal fibroblasts) grown together to make a bi-layered construct (a cellularized scaffold).

Key features of the study:

• This report provides in-depth analysis of the global bioengineered artificial skin market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2023–2030), considering 2022 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global bioengineered artificial skin market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include ConvaTec Group plc, LifeNet Health, Zimmer Biomet Holdings, Inc., Medline Industries, Inc., Acelity L.P. Inc., Johnson & Johnson, Stryker Corporation, TissueTech, Inc., Stratatech Corporation, Avita Medical, Mölnlycke Health Care AB, MiMedx Group, Inc., Organogenesis Holdings Inc., Smith & Nephew plc, and Integra LifeSciences Holdings Corporation, among others.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global bioengineered artificial skin market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global bioengineered artificial skin market.

Detailed Segmentation:

• Global Bioengineered Artificial Skin Market, By Product Type:

Bilayered Bioengineered Artificial Skin

Trilayered Bioengineered Artificial Skin

Others

• Global Bioengineered Artificial Skin Market, By Application:

Chronic Wounds

• Diabetic Foot Ulcers
• Venous Leg Ulcers
• Pressure Ulcers
• Others

Acute Wounds

• Burns
• Surgical Wounds
• Others

Others

• Global Bioengineered Artificial Skin Market, By End User:

Hospitals

Clinics

Others

• Global Bioengineered Artificial Skin Market, By Geography:

North America

Europe

Asia Pacific

Latin America

Middle East & Africa

• Company Profiles:

ConvaTec Group plc

LifeNet Health

Zimmer Biomet Holdings, Inc.

Medline Industries, Inc.

Acelity L.P. Inc.

Johnson & Johnson

Stryker Corporation

TissueTech, Inc.

Stratatech Corporation

Avita Medical

Mölnlycke Health Care AB

MiMedx Group, Inc.

Organogenesis Holdings Inc.

Smith & Nephew plc

Integra LifeSciences Holdings Corporation